Bridgeway Capital Management’s Fibrocell Science Inc. FCSC Stock Holding History

Bridgeway Capital Management’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,207	Closed	-$174K	–	1558
2015 Q2	$174K	Hold	2,207	–	–	﹤0.01%	1374
2015 Q1	$149K	Hold	2,207	–	–	﹤0.01%	1368
2014 Q4	$85K	Sell	2,207 -6,514	-75%	-$263K	﹤0.01%	1403
2014 Q3	$379K	Hold	8,721	–	–	0.01%	1210
2014 Q2	$522K	Buy	8,721 +654	+8%	+$36.5K	0.01%	1071
2014 Q1	$633K	Buy	+8,067	New	+$625K	0.02%	971

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bridgeway Capital Management's FCSC Position: Q3 2015 in Review

Bridgeway Capital Management sold out of Fibrocell Science Inc. (FCSC) in Q3 2015, closing a stake of 2,207 shares — an estimated $174K sold.

Bridgeway Capital Management first reported a position in FCSC in Q1 2014 and held it in 6 quarters. The position peaked at $633K in Q1 2014. 53 funds tracked by Wall St. Rank hold FCSC as of Q3 2015.

Bridgeway Capital Management reported no remaining Fibrocell Science Inc. position as of Q3 2015 after selling out during the quarter.
Bridgeway Capital Management sold 2,207 Fibrocell Science Inc. shares in Q3 2015, an estimated $174K.
Bridgeway Capital Management first reported a position in Fibrocell Science Inc. in Q1 2014 and held it in 6 quarters.
Bridgeway Capital Management's Fibrocell Science Inc. position peaked at $633K in Q1 2014.
53 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q3 2015.

Based on Bridgeway Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.